Literature DB >> 21720459

Left ventricular function improves after pulmonary valve replacement in patients with previous right ventricular outflow tract reconstruction and biventricular dysfunction.

Colin Kane1, Brian Kogon, Maria Pernetz, Michael McConnell, Paul Kirshbom, Katherine Rodby, Wendy M Book.   

Abstract

Congenital heart defects that have a component of right ventricular outflow tract obstruction, such as tetralogy of Fallot, are frequently palliated in childhood by disruption of the pulmonary valve. Although this can provide an initial improvement in quality of life, these patients are often left with severe pulmonary valve insufficiency. Over time, this insufficiency can lead to enlargement of the right ventricle and to the deterioration of right ventricular systolic and diastolic function. Pulmonary valve replacement in these patients decreases right ventricular volume overload and improves right ventricular performance. To date, few studies have examined the effects of pulmonary valve replacement on left ventricular function in patients with biventricular dysfunction. We sought to perform such an evaluation.Records of adult patients who had undergone pulmonary valve replacement from January 2003 through November 2006 were analyzed retrospectively. We reviewed preoperative and postoperative echocardiograms and calculated left ventricular function in 38 patients.In the entire cohort, the mean left ventricular ejection fraction increased by a mean of 0.07 after pulmonary valve replacement, which was a statistically significant change (P < 0.01). In patients with preoperative ejection fractions of less than 0.50, mean ejection fractions increased by 0.10.We conclude that pulmonary valve replacement in patients with biventricular dysfunction arising from severe pulmonary insufficiency and right ventricular enlargement can improve left ventricular function. Prospective studies are needed to verify this finding.

Entities:  

Keywords:  Adult; cardiac output; cardiac volume; heart valve prosthesis; hemodynamics; pulmonary valve insufficiency/complications/surgery; reoperation; retrospective studies; stroke volume; tetralogy of Fallot/surgery; time factors; treatment outcome; ventricular dysfunction, left; ventricular dysfunction, right

Mesh:

Substances:

Year:  2011        PMID: 21720459      PMCID: PMC3113116     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  12 in total

1.  Right ventricular function in adults with repaired tetralogy of Fallot assessed with cardiovascular magnetic resonance imaging: detrimental role of right ventricular outflow aneurysms or akinesia and adverse right-to-left ventricular interaction.

Authors:  Periklis A Davlouros; Philip J Kilner; Tim S Hornung; Wei Li; Jane M Francis; James C C Moon; Gillian C Smith; Tri Tat; Dudley J Pennell; Michael A Gatzoulis
Journal:  J Am Coll Cardiol       Date:  2002-12-04       Impact factor: 24.094

2.  Long-term results of total repair of tetralogy of Fallot in childhood.

Authors:  P J Horneffer; K G Zahka; S A Rowe; T A Manolio; V L Gott; B A Reitz; T J Gardner
Journal:  Ann Thorac Surg       Date:  1990-08       Impact factor: 4.330

3.  Right and left ventricular systolic function late after repair of tetralogy of Fallot.

Authors:  M A Gatzoulis; J T Elliott; V Guru; S C Siu; M A Warsi; G D Webb; W G Williams; P Liu; P R McLaughlin
Journal:  Am J Cardiol       Date:  2000-12-15       Impact factor: 2.778

4.  Long-term outcome in patients undergoing surgical repair of tetralogy of Fallot.

Authors:  J G Murphy; B J Gersh; D D Mair; V Fuster; M D McGoon; D M Ilstrup; D C McGoon; J W Kirklin; G K Danielson
Journal:  N Engl J Med       Date:  1993-08-26       Impact factor: 91.245

5.  Factors that exaggerate the deleterious effects of pulmonary insufficiency on the right ventricle after tetralogy repair. Surgical implications.

Authors:  M N Ilbawi; F S Idriss; S Y DeLeon; A J Muster; S S Gidding; T E Berry; M H Paul
Journal:  J Thorac Cardiovasc Surg       Date:  1987-01       Impact factor: 5.209

6.  Improved right ventricular function following late pulmonary valve replacement for residual pulmonary insufficiency or stenosis.

Authors:  E L Bove; R E Kavey; C J Byrum; H M Sondheimer; M S Blackman; F D Thomas
Journal:  J Thorac Cardiovasc Surg       Date:  1985-07       Impact factor: 5.209

7.  Long-term valvular function after total repair of tetralogy of Fallot. Relation to ventricular arrhythmias.

Authors:  K G Zahka; P J Horneffer; S A Rowe; C A Neill; T A Manolio; L Kidd; T J Gardner
Journal:  Circulation       Date:  1988-11       Impact factor: 29.690

8.  Restoration of the pulmonary valve reduces right ventricular volume overload after previous repair of tetralogy of Fallot.

Authors:  K G Warner; J E Anderson; D R Fulton; D D Payne; R L Geggel; G R Marx
Journal:  Circulation       Date:  1993-11       Impact factor: 29.690

9.  The influence of pulmonary insufficiency on ventricular function following repair of tetralogy of Fallot. Evaluation using radionuclide ventriculography.

Authors:  E L Bove; C J Byrum; F D Thomas; R E Kavey; H M Sondheimer; M S Blackman; F B Parker
Journal:  J Thorac Cardiovasc Surg       Date:  1983-05       Impact factor: 5.209

10.  Magnetic resonance imaging to assess the hemodynamic effects of pulmonary valve replacement in adults late after repair of tetralogy of fallot.

Authors:  Hubert W Vliegen; Alexander van Straten; Albert de Roos; Arno A W Roest; Paul H Schoof; Aeilko H Zwinderman; Jaap Ottenkamp; Ernst E van der Wall; Mark G Hazekamp
Journal:  Circulation       Date:  2002-09-24       Impact factor: 29.690

View more
  1 in total

1.  Haemodynamic consequences of targeted single- and dual-site right ventricular pacing in adults with congenital heart disease undergoing surgical pulmonary valve replacement.

Authors:  Carla M Plymen; Malcolm Finlay; Victor Tsang; Justin O'leary; Nathalie Picaut; Shay Cullen; Fiona Walker; John E Deanfield; T Y Hsia; Aidan P Bolger; Pier D Lambiase
Journal:  Europace       Date:  2014-11-04       Impact factor: 5.214

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.